Get to Know Geoff
Get to Know Geoff
- Drafting and negotiating a collaboration for a variety of cell therapy programs
- Drafting and negotiating an exclusive outlicense of transmembrane immunomodulatory protein technology, valued at more than US$535 million
- Drafting and negotiating a worldwide profit share collaboration for six biosimilar programs, including upfront and milestone payments of US$245 million
- Drafting and negotiating a genomics alliance agreement for the discovery and development of novel therapeutic approaches to major chronic diseases within oncology, neuroscience, and immunology
- Drafting and negotiating separate US and EU commercial manufacturing and supply agreements for a medication used to treat medullary thyroid cancer and a second line treatment for renal cell carcinoma
- Drafting and negotiating a master collaboration agreement and ancillary agreements for a variety of immune-oncology programs, a transaction valued at US$1 billion
- Drafting and negotiating a license agreement for the commercialization in Europe and certain other territories of a drug used for the treatment of hyperkalemia, including an upfront cash payment of US$40 million, milestone payments of US$125 million, and tiered double-digit royalties
- Drafting and negotiating a development program agreement for gene therapy treatments targeting cystic fibrosis, generating more than US$3.5 million in funding
- Drafting and negotiating a master collaboration agreement with one of the largest privately held US corporation for the development of a methanotrophic bacteria program
- Drafting and negotiating an amendment terminating collaboration on an experimental drug candidate for the treatment of cancer
- Intellectual property due diligence and drafting and negotiating US$2.1 billion merger of two pharmaceutical companies
- Intellectual property due diligence for underwriters as part of the process for an initial public offering and follow-on offerings, including drafting and negotiating aspects of underwriting agreement
Admissions
Bar Admissions
- California
Court Admissions
- California Supreme Court
Education
- University of California College of the Law, San Francisco, 2000: cum laude; Order of the Coif
- University of California, Berkeley, Ph.D., Biophysical Chemistry, 1997
- Massachusetts Institute of Technology, B.S., Chemistry, 1992; MIT Undergraduate Research Opportunities Program Award
Honors & Awards
- Recognized by The Legal 500 for his work in the life sciences industry (2019)
Professional Activities
Member
- California Bar Association
Speaker
- “Strategic Collaborations: Setting Up for Success” at J&J’s Legal Webinar Series for Life Sciences Entrepreneurs (July 7th, 2020)
- “Best Licensing Practices in Life Science IP: Negotiating and Executing Transaction,” The Knowledge Group (January 30th, 2019)
- 2019 China Renaissance Healthcare Event (January 10th, 2019)
- “Addressing Risk and Opportunities in Life Sciences IP Due Diligence,” The Knowledge Group (November 14th, 2018)
Related Practices
Related Industries